Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation

Shane R. Cunha, Thomas J. Hund, Seyed Hashemi, Niels Voigt, Na Li, Patrick Wright, Olha Koval, Jingdong Li, Hjalti Gudmundsson, Richard J. Gumina, Matthias Karck, Jean Jacques Schott, Vincent Probst, Herve Le Marec, Mark Anderson, Dobromir Dobrev, Xander H T Wehrens, Peter J. Mohler

Research output: Contribution to journalArticle

Abstract

Background-: Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting >2 million patients in the United States alone. Despite decades of research, surprisingly little is known regarding the molecular pathways underlying the pathogenesis of AF. ANK2 encodes ankyrin-B, a multifunctional adapter molecule implicated in membrane targeting of ion channels, transporters, and signaling molecules in excitable cells. Methods and Results-: In the present study, we report early-onset AF in patients harboring loss-of-function mutations in ANK2. In mice, we show that ankyrin-B deficiency results in atrial electrophysiological dysfunction and increased susceptibility to AF. Moreover, ankyrin-B+/- atrial myocytes display shortened action potentials, consistent with human AF. Ankyrin-B is expressed in atrial myocytes, and we demonstrate its requirement for the membrane targeting and function of a subgroup of voltage-gated Ca2+ channels (Ca v1.3) responsible for low voltage-activated L-type Ca2+ current. Ankyrin-B is associated directly with Cav1.3, and this interaction is regulated by a short, highly conserved motif specific to Ca v1.3. Moreover, loss of ankyrin-B in atrial myocytes results in decreased Cav1.3 expression, membrane localization, and function sufficient to produce shortened atrial action potentials and arrhythmias. Finally, we demonstrate reduced ankyrin-B expression in atrial samples of patients with documented AF, further supporting an association between ankyrin-B and AF. Conclusions-: These findings support that reduced ankyrin-B expression or mutations in ANK2 are associated with AF. Additionally, our data demonstrate a novel pathway for ankyrin-B-dependent regulation of Cav1.3 channel membrane targeting and regulation in atrial myocytes.

Original languageEnglish (US)
Pages (from-to)1212-1222
Number of pages11
JournalCirculation
Volume124
Issue number11
DOIs
StatePublished - Sep 13 2011
Externally publishedYes

Fingerprint

Ankyrins
Protein Transport
Atrial Fibrillation
Membrane Proteins
Muscle Cells
Ion Channels
Action Potentials
Membranes
Cardiac Arrhythmias
Mutation

Keywords

  • Arrhythmia (mechanisms)
  • cytoskeleton
  • ion channel
  • protein trafficking

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Cunha, S. R., Hund, T. J., Hashemi, S., Voigt, N., Li, N., Wright, P., ... Mohler, P. J. (2011). Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. Circulation, 124(11), 1212-1222. https://doi.org/10.1161/CIRCULATIONAHA.111.023986

Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. / Cunha, Shane R.; Hund, Thomas J.; Hashemi, Seyed; Voigt, Niels; Li, Na; Wright, Patrick; Koval, Olha; Li, Jingdong; Gudmundsson, Hjalti; Gumina, Richard J.; Karck, Matthias; Schott, Jean Jacques; Probst, Vincent; Le Marec, Herve; Anderson, Mark; Dobrev, Dobromir; Wehrens, Xander H T; Mohler, Peter J.

In: Circulation, Vol. 124, No. 11, 13.09.2011, p. 1212-1222.

Research output: Contribution to journalArticle

Cunha, SR, Hund, TJ, Hashemi, S, Voigt, N, Li, N, Wright, P, Koval, O, Li, J, Gudmundsson, H, Gumina, RJ, Karck, M, Schott, JJ, Probst, V, Le Marec, H, Anderson, M, Dobrev, D, Wehrens, XHT & Mohler, PJ 2011, 'Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation', Circulation, vol. 124, no. 11, pp. 1212-1222. https://doi.org/10.1161/CIRCULATIONAHA.111.023986
Cunha, Shane R. ; Hund, Thomas J. ; Hashemi, Seyed ; Voigt, Niels ; Li, Na ; Wright, Patrick ; Koval, Olha ; Li, Jingdong ; Gudmundsson, Hjalti ; Gumina, Richard J. ; Karck, Matthias ; Schott, Jean Jacques ; Probst, Vincent ; Le Marec, Herve ; Anderson, Mark ; Dobrev, Dobromir ; Wehrens, Xander H T ; Mohler, Peter J. / Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. In: Circulation. 2011 ; Vol. 124, No. 11. pp. 1212-1222.
@article{407b9574ebca4adf84de527b50cd865c,
title = "Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation",
abstract = "Background-: Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting >2 million patients in the United States alone. Despite decades of research, surprisingly little is known regarding the molecular pathways underlying the pathogenesis of AF. ANK2 encodes ankyrin-B, a multifunctional adapter molecule implicated in membrane targeting of ion channels, transporters, and signaling molecules in excitable cells. Methods and Results-: In the present study, we report early-onset AF in patients harboring loss-of-function mutations in ANK2. In mice, we show that ankyrin-B deficiency results in atrial electrophysiological dysfunction and increased susceptibility to AF. Moreover, ankyrin-B+/- atrial myocytes display shortened action potentials, consistent with human AF. Ankyrin-B is expressed in atrial myocytes, and we demonstrate its requirement for the membrane targeting and function of a subgroup of voltage-gated Ca2+ channels (Ca v1.3) responsible for low voltage-activated L-type Ca2+ current. Ankyrin-B is associated directly with Cav1.3, and this interaction is regulated by a short, highly conserved motif specific to Ca v1.3. Moreover, loss of ankyrin-B in atrial myocytes results in decreased Cav1.3 expression, membrane localization, and function sufficient to produce shortened atrial action potentials and arrhythmias. Finally, we demonstrate reduced ankyrin-B expression in atrial samples of patients with documented AF, further supporting an association between ankyrin-B and AF. Conclusions-: These findings support that reduced ankyrin-B expression or mutations in ANK2 are associated with AF. Additionally, our data demonstrate a novel pathway for ankyrin-B-dependent regulation of Cav1.3 channel membrane targeting and regulation in atrial myocytes.",
keywords = "Arrhythmia (mechanisms), cytoskeleton, ion channel, protein trafficking",
author = "Cunha, {Shane R.} and Hund, {Thomas J.} and Seyed Hashemi and Niels Voigt and Na Li and Patrick Wright and Olha Koval and Jingdong Li and Hjalti Gudmundsson and Gumina, {Richard J.} and Matthias Karck and Schott, {Jean Jacques} and Vincent Probst and {Le Marec}, Herve and Mark Anderson and Dobromir Dobrev and Wehrens, {Xander H T} and Mohler, {Peter J.}",
year = "2011",
month = "9",
day = "13",
doi = "10.1161/CIRCULATIONAHA.111.023986",
language = "English (US)",
volume = "124",
pages = "1212--1222",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation

AU - Cunha, Shane R.

AU - Hund, Thomas J.

AU - Hashemi, Seyed

AU - Voigt, Niels

AU - Li, Na

AU - Wright, Patrick

AU - Koval, Olha

AU - Li, Jingdong

AU - Gudmundsson, Hjalti

AU - Gumina, Richard J.

AU - Karck, Matthias

AU - Schott, Jean Jacques

AU - Probst, Vincent

AU - Le Marec, Herve

AU - Anderson, Mark

AU - Dobrev, Dobromir

AU - Wehrens, Xander H T

AU - Mohler, Peter J.

PY - 2011/9/13

Y1 - 2011/9/13

N2 - Background-: Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting >2 million patients in the United States alone. Despite decades of research, surprisingly little is known regarding the molecular pathways underlying the pathogenesis of AF. ANK2 encodes ankyrin-B, a multifunctional adapter molecule implicated in membrane targeting of ion channels, transporters, and signaling molecules in excitable cells. Methods and Results-: In the present study, we report early-onset AF in patients harboring loss-of-function mutations in ANK2. In mice, we show that ankyrin-B deficiency results in atrial electrophysiological dysfunction and increased susceptibility to AF. Moreover, ankyrin-B+/- atrial myocytes display shortened action potentials, consistent with human AF. Ankyrin-B is expressed in atrial myocytes, and we demonstrate its requirement for the membrane targeting and function of a subgroup of voltage-gated Ca2+ channels (Ca v1.3) responsible for low voltage-activated L-type Ca2+ current. Ankyrin-B is associated directly with Cav1.3, and this interaction is regulated by a short, highly conserved motif specific to Ca v1.3. Moreover, loss of ankyrin-B in atrial myocytes results in decreased Cav1.3 expression, membrane localization, and function sufficient to produce shortened atrial action potentials and arrhythmias. Finally, we demonstrate reduced ankyrin-B expression in atrial samples of patients with documented AF, further supporting an association between ankyrin-B and AF. Conclusions-: These findings support that reduced ankyrin-B expression or mutations in ANK2 are associated with AF. Additionally, our data demonstrate a novel pathway for ankyrin-B-dependent regulation of Cav1.3 channel membrane targeting and regulation in atrial myocytes.

AB - Background-: Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting >2 million patients in the United States alone. Despite decades of research, surprisingly little is known regarding the molecular pathways underlying the pathogenesis of AF. ANK2 encodes ankyrin-B, a multifunctional adapter molecule implicated in membrane targeting of ion channels, transporters, and signaling molecules in excitable cells. Methods and Results-: In the present study, we report early-onset AF in patients harboring loss-of-function mutations in ANK2. In mice, we show that ankyrin-B deficiency results in atrial electrophysiological dysfunction and increased susceptibility to AF. Moreover, ankyrin-B+/- atrial myocytes display shortened action potentials, consistent with human AF. Ankyrin-B is expressed in atrial myocytes, and we demonstrate its requirement for the membrane targeting and function of a subgroup of voltage-gated Ca2+ channels (Ca v1.3) responsible for low voltage-activated L-type Ca2+ current. Ankyrin-B is associated directly with Cav1.3, and this interaction is regulated by a short, highly conserved motif specific to Ca v1.3. Moreover, loss of ankyrin-B in atrial myocytes results in decreased Cav1.3 expression, membrane localization, and function sufficient to produce shortened atrial action potentials and arrhythmias. Finally, we demonstrate reduced ankyrin-B expression in atrial samples of patients with documented AF, further supporting an association between ankyrin-B and AF. Conclusions-: These findings support that reduced ankyrin-B expression or mutations in ANK2 are associated with AF. Additionally, our data demonstrate a novel pathway for ankyrin-B-dependent regulation of Cav1.3 channel membrane targeting and regulation in atrial myocytes.

KW - Arrhythmia (mechanisms)

KW - cytoskeleton

KW - ion channel

KW - protein trafficking

UR - http://www.scopus.com/inward/record.url?scp=80052755777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052755777&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.111.023986

DO - 10.1161/CIRCULATIONAHA.111.023986

M3 - Article

VL - 124

SP - 1212

EP - 1222

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 11

ER -